Novavax Looks To Increase Runway Through Strategic Alliance With India’s Cadila
This article was originally published in The Pink Sheet Daily
Executive Summary
Partnership will create India-based joint venture to sell Novavax’s VLP anti-infective vaccines.
You may also be interested in...
PIPE Proceeds In Hand, Novavax Looks To Score With Two Late-Stage Flu Vaccines
Vaccine-focused biotech says it has sufficient cash to continue business strategy through third-quarter 2009.
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.